Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes F Fahrmann

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Lipids in Health and Disease|March 19, 2013
Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabineJohannes F Fahrmann, W Elaine Hardman
Biomarker Insights|September 24, 2015
Genomic, Proteomic, and Metabolomic Data Integration StrategiesKwanjeera Wanichthanarak, Johannes F Fahrmann, Dmitry Grapov
Electrophoresis|June 17, 2017
Review of emerging metabolomic tools and resources: 2015-2016Biswapriya B Misra, Johannes F Fahrmann, Dmitry Grapov
Cell Chemical Biology|March 24, 2020
A Promising CPS1 Inhibitor Keeping Ammonia from Fueling CancerAyumu Taguchi, Johannes F Fahrmann, Samir M Hanash
Frontiers in Oncology|April 9, 2020
Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung CancerJohannes F Fahrmann, Jody V Vykoukal, Edwin J Ostrin
Cancer Metastasis Reviews|May 18, 2020
Caveolin and lipid domains-close companions in managing cellular pathwaysJody V Vykoukal, Johannes F Fahrmann, Timothy C Thompson
Translational Lung Cancer Research|July 28, 2018
Blood based biomarkers beyond genomics for lung cancer screeningSamir M Hanash, Edwin Justin Ostrin, Johannes F Fahrmann
Seminars in Immunology|January 12, 2020
Development of autoantibody signatures for common cancersMakoto Kobayashi, Hiroyuki Katayama, Johannes F Fahrmann, et al.
Cancers|September 28, 2021
Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic ApplicationsTaketo Kato, Jody V Vykoukal, Johannes F Fahrmann, et al.
Cells|June 26, 2020
Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer TherapyTaketo Kato, Johannes F Fahrmann, Samir M Hanash, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Lipids in Health and Disease|March 19, 2013
Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabineJohannes F Fahrmann, W Elaine Hardman
Biomarker Insights|September 24, 2015
Genomic, Proteomic, and Metabolomic Data Integration StrategiesKwanjeera Wanichthanarak, Johannes F Fahrmann, Dmitry Grapov
Electrophoresis|June 17, 2017
Review of emerging metabolomic tools and resources: 2015-2016Biswapriya B Misra, Johannes F Fahrmann, Dmitry Grapov
Cell Chemical Biology|March 24, 2020
A Promising CPS1 Inhibitor Keeping Ammonia from Fueling CancerAyumu Taguchi, Johannes F Fahrmann, Samir M Hanash
Frontiers in Oncology|April 9, 2020
Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung CancerJohannes F Fahrmann, Jody V Vykoukal, Edwin J Ostrin
Cancer Metastasis Reviews|May 18, 2020
Caveolin and lipid domains-close companions in managing cellular pathwaysJody V Vykoukal, Johannes F Fahrmann, Timothy C Thompson
Translational Lung Cancer Research|July 28, 2018
Blood based biomarkers beyond genomics for lung cancer screeningSamir M Hanash, Edwin Justin Ostrin, Johannes F Fahrmann
Seminars in Immunology|January 12, 2020
Development of autoantibody signatures for common cancersMakoto Kobayashi, Hiroyuki Katayama, Johannes F Fahrmann, et al.
Cancers|September 28, 2021
Extracellular Vesicles in Lung Cancer: Prospects for Diagnostic and Therapeutic ApplicationsTaketo Kato, Jody V Vykoukal, Johannes F Fahrmann, et al.
Cells|June 26, 2020
Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer TherapyTaketo Kato, Johannes F Fahrmann, Samir M Hanash, et al.
Pageof 9